Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Ignoffo

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Annals of Internal Medicine|September 15, 1989
Correction: Cancer Chemotherapy Protocols and dose of chlorambucilR J Ignoffo, P Forni
Cancer Practice|March 20, 2002
Temozolomide. A new option for high-grade astrocytomasJ Schwenka, R J Ignoffo
Clinical Pharmacy|January 1, 1990
Error in Cancer Chemotherapy ProtocolsP Forni, R J Ignoffo
Cancer Practice|October 28, 1997
Dolasetron. A new 5-hydroxytryptamine3 receptor antagonistY F Hui, R J Ignoffo
Cancer Treatment Reviews|March 1, 1980
Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugsR J Ignoffo, M A Friedman
Cancer Practice|March 1, 1997
Docetaxel in anthracycline-resistant metastatic breast cancerY F Hui, R J Ignoffo
Cancer Treatment Reviews|December 1, 1980
A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958)M A Friedman, R J Ignoffo
Journal of the American Pharmaceutical Association|October 1, 1972
GlaucomaT G Tong, R J Ignoffo
DICP : the Annals of Pharmacotherapy|January 1, 1991
Erythromycin and cyclosporine drug interactionR J Ignoffo, L E Kim
Cancer Practice|March 7, 2002
Arsenic trioxide for the treatment of acute promyelocytic leukemiaM S Lam, R J Ignoffo
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Annals of Internal Medicine|September 15, 1989
Correction: Cancer Chemotherapy Protocols and dose of chlorambucilR J Ignoffo, P Forni
Cancer Practice|March 20, 2002
Temozolomide. A new option for high-grade astrocytomasJ Schwenka, R J Ignoffo
Clinical Pharmacy|January 1, 1990
Error in Cancer Chemotherapy ProtocolsP Forni, R J Ignoffo
Cancer Practice|October 28, 1997
Dolasetron. A new 5-hydroxytryptamine3 receptor antagonistY F Hui, R J Ignoffo
Cancer Treatment Reviews|March 1, 1980
Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugsR J Ignoffo, M A Friedman
Cancer Practice|March 1, 1997
Docetaxel in anthracycline-resistant metastatic breast cancerY F Hui, R J Ignoffo
Cancer Treatment Reviews|December 1, 1980
A review of the United States clinical experience of the fluoropyrimidine, ftorafur (NSC-148958)M A Friedman, R J Ignoffo
Journal of the American Pharmaceutical Association|October 1, 1972
GlaucomaT G Tong, R J Ignoffo
DICP : the Annals of Pharmacotherapy|January 1, 1991
Erythromycin and cyclosporine drug interactionR J Ignoffo, L E Kim
Cancer Practice|March 7, 2002
Arsenic trioxide for the treatment of acute promyelocytic leukemiaM S Lam, R J Ignoffo
Pageof 3